Dr. Roy Mitchel Fleischmann , MD
Specialist • Dallas, TX
8144 Walnut Hill Ln, Suite 800
Dallas, TX 752314388
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 15, 2005; this date does not establish years in practice.
-
Published CMS data list 12 Medicare Part D prescriptions, including refills, in 2019.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Published rows only; this is not a quality measure.
-
Published Part D records, 2019:
- Alprazolam — 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 2,368 in 2014 to 12 in 2019.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2014–2019.
Practice Location & Contact Primary Location
8144 Walnut Hill Ln
Suite 800
Dallas, TX 752314388
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
12 standardized 30-day fills in 2019
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$31 in 2019
The total cost of these prescriptions in 2019, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2019.
Open Payments general payments, program year 2025
All general payments: $81,560.30 across 154 records.
By nature of payment (3 largest of 7)
- Consulting Fee: $34,344.98 across 18 records.
- Grant: $25,000.00 across 1 record.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $9,343.45 across 5 records.
Reporting-company totals (3 largest of 13)
- ABBVIE INC.: $29,500.00 across 2 records.
- Janssen Pharmaceuticals, Inc: $13,561.72 across 55 records.
- Pfizer Inc.: $11,567.62 across 19 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Dallas and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Fleischmann are from 2019.
154 active clinicians are listed under Specialist with a practice address in Dallas, TX (1,712 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Dallas
3.2% of these 154 clinicians have the CMS telehealth indicator.
15.6% of these 154 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 99% from 2,368 in 2014 to 12 in 2019.
- 2014: 2,368
- 2015: 1,693
- 2016: 51
- 2018: 16
- 2019: 12
-
30-day fills
30-day fills decreased 100% from 3,855 in 2014 to 12 in 2019.
- 2014: 3,855
- 2015: 2,665
- 2016: 63
- 2018: 18
- 2019: 12
-
Part D drug cost
Part D drug cost decreased 100% from $723,944 in 2014 to $31 in 2019.
- 2014: $723,944
- 2015: $354,984
- 2016: $3,873
- 2018: $732
- 2019: $31
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 58% from $197,170.91 in 2021 to $82,340.30 in 2025.
- 2021: $197,170.91
- 2022: $168,100.05
- 2023: $121,832.42
- 2024: $91,772.93
- 2025: $82,340.30
Sources: CMS Medicare Part D Prescribers (2019), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 155 records totaling $82,340.30.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Grant
Cash or cash equivalent
|
RINVOQ | General | $25,000.00 |
| Merck Sharp & Dohme LLC |
Consulting Fee
Cash or cash equivalent
|
— | General | $6,695.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
TREMFYA | General | $6,000.00 |
| Pfizer Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XELJANZ | General | $5,250.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
RINVOQ | General | $4,500.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
— | General | $4,375.00 |
| Pfizer Inc. |
Honoraria
Cash or cash equivalent
|
— | General | $2,478.40 |
| Novartis Pharmaceuticals Corporation |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $2,160.00 |
| Eisai Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,000.00 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
TREMFYA | General | $1,956.80 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
TREMFYA | General | $1,905.60 |
| Novartis Pharmaceuticals Corporation |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $1,782.40 |
| Janssen Pharmaceuticals, Inc |
Consulting Fee
Cash or cash equivalent
|
TREMFYA | General | $952.80 |
| Pfizer Inc. |
Travel and Lodging
In-kind items and services
|
— | General | $910.09 |
| Galderma Laboratories, L.P. |
Consulting Fee
Cash or cash equivalent
|
NEMLUVIO | General | $800.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $800.00 |
| Novartis Pharmaceuticals Corporation |
Consulting Fee
Cash or cash equivalent
|
COSENTYX | General | $800.00 |
| Gilead Sciences, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $800.00 |
| Pfizer Inc. |
General
In-kind items and services
|
XELJANZ | Research | $780.00 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $719.19 |
| Janssen Pharmaceuticals, Inc |
Travel and Lodging
In-kind items and services
|
TREMFYA | General | $718.55 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $696.00 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
— | General | $656.25 |
| Eli Lilly and Company |
Consulting Fee
Cash or cash equivalent
|
— | General | $656.25 |
| Novartis Pharmaceuticals Corporation |
Travel and Lodging
In-kind items and services
|
— | General | $654.51 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2019.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alprazolam | Alprazolam | 12 | 360 | $30.81 | — |
Source: CMS Part D by Provider and Drug, 2019; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Nurse Practitioner - Adult Health
Registered Nurse, Master of Science, Nurse Practitioner (Certified)
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Internal Medicine - Rheumatology
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Rheumatology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History
NPI enumerated July 15, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Specialists in Dallas
- Dr. J Wyatt, MD
- Dr. Thomas Diliberti, MD PA
- Dr. David Feinstein, MD
- Dr. Wesley Herman, MD
- Dr. Neil Atlin, DO
- Deborah Westergaard, MDPA
Mailing Address
8144 Walnut Hill Ln, Suite 800
Dallas, TX 752314388
Phone: 2145400700